Skip to main content

Series B Biotechnology Companies

Explore 430 biotechnology startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
430
Total Funding
$1.0B
Avg Funding
$40.6M
Cities
19

Export 430 Series B Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Espoo, Finland
$16.2M
raised

Enifer is a mycoprotein company that produces a fungal fermentation product to upcycle agrifood industry byproducts.

May 2024
Series B

Founder Contacts

41,000+ verified contacts

Abingdon, United Kingdom
$50.0M
raised

We are advancing novel antigen modulation technology that controls T cells to guide the immune system.

May 2024
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom

NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.

May 2024
Series B

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$120.0M
raised

Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.

May 2024
Series B

Founder Contacts

41,000+ verified contacts

San Carlos, United States
$35.0M
raised

Elegen is a biotechnology company that develops microfluidic technology.

May 2024
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Los Angeles, United States
$712K
raised

Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality.

May 2024
Series B

Founder Contacts

41,000+ verified contacts

$6.2M
raised

AceRNA Technologies is a biotech startup that develops patient-centric genetic therapies with RNA switch technology for drug discovery.

May 2024
Series B

Founder Contacts

41,000+ verified contacts

Wellesley, United States
$24.0M
raised

Qlaris Bio focuses on developing first-in-class therapies for serious and debilitating ophthalmic diseases.

Apr 2024
Series B

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom
$25.0M
raised

Pathios Therapeutics is a biotech company focused on the development of therapies for autoimmune diseases and cancer.

Apr 2024
Series B

Founder Contacts

41,000+ verified contacts

San Diego, United States
$132.0M
raised

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

Apr 2024
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Schlieren, Switzerland
$15.6M
raised

Hemotune is a medical device company that develops a therapeutic blood purification platform for the treatment of health ailments.

Mar 2024
Series B

Founder Contacts

41,000+ verified contacts

San Diego, United States
$175.0M
raised

Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases.

Mar 2024
Series B

Founder Contacts

41,000+ verified contacts

Richmond, United States
$22.4M
raised

X-Therma is a biotechnology firm that develops a convergent biopreservation platform to advance regenerative medicine.

Mar 2024
Series B

Founder Contacts

41,000+ verified contacts

$29.5M
raised

Infinited Fiber Company is on a mission to make circular fashion and textiles an everyday reality

Mar 2024
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$62.0M
raised

Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.

Mar 2024
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Niigata, Japan
$3.2M
raised

UniBio is a biotech company that aims to produce useful proteins in plant cells via synthesis and the transient gene expression method.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

Seattle, United States

Cyrus Biotechnology is a developer of Rosetta software platform that solves drug discovery problems.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

Burlingame, United States
$10.5M
raised

Trace Genomics provides genetic insights into soil, helping farmers optimize their agricultural practices for better crop yield.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

Torrance, United States
$35.0M
raised

Athos develops AI-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

The Woodlands, United States
$6.6M
raised

Othram aims to revolutionize how forensic cases are solved, justice is served, and families are mended.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$42.5M
raised

NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

Seattle, United States
$112.0M
raised

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

Carmel, United States
$30.0M
raised

Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$56.0M
raised

Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

Seattle, United States
$4.7M
raised

Proniras focuses on development of a new parenteral medical countermeasure (MCM) to treat seizures and brain injury.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

Showing 226 to 250 of 430 companies

Ready to Connect with Series B Biotechnology Startups?

Get verified founder emails, funding details, and company data for 430 series b biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked